Nivolumab plus ipilimumab combination therapy in patients with advanced hepatocellular carcinoma previously treated with sorafenib: 5-year results from CheckMate 040.
- DOI
- 10.1016/j.annonc.2024.03.005
- Published
- 2024-05-22
- Container
- Ann Oncol
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.annonc.2024.03.005,
title = {Nivolumab plus ipilimumab combination therapy in patients with advanced hepatocellular carcinoma previously treated with sorafenib: 5-year results from CheckMate 040.},
author = {Melero I and Yau T and Kang YK and Kim TY and Santoro A and Sangro B and Kudo M and Hou MM and Matilla A and Tovoli F and Knox J and He AR and El-Rayes B and Acosta-Rivera M and Lim HY and Soleymani S and Yao J and Neely J and Tschaika M and Hsu C and El-Khoueiry AB.},
year = {2024},
journal = {Ann Oncol},
doi = {10.1016/j.annonc.2024.03.005},
url = {https://doi.org/10.1016/j.annonc.2024.03.005}
}RIS
TY - JOUR TI - Nivolumab plus ipilimumab combination therapy in patients with advanced hepatocellular carcinoma previously treated with sorafenib: 5-year results from CheckMate 040. AU - Melero I AU - Yau T AU - Kang YK AU - Kim TY AU - Santoro A AU - Sangro B AU - Kudo M AU - Hou MM AU - Matilla A AU - Tovoli F AU - Knox J AU - He AR AU - El-Rayes B AU - Acosta-Rivera M AU - Lim HY AU - Soleymani S AU - Yao J AU - Neely J AU - Tschaika M AU - Hsu C AU - El-Khoueiry AB. PY - 2024 JO - Ann Oncol DO - 10.1016/j.annonc.2024.03.005 UR - https://doi.org/10.1016/j.annonc.2024.03.005 ER -
APA
I, M., T, Y., YK, K., TY, K., A, S., B, S., M, K., MM, H., A, M., F, T., J, K., AR, H., B, E., M, A., HY, L., S, S., J, Y., J, N., M, T., C, H., & AB., E. (2024). Nivolumab plus ipilimumab combination therapy in patients with advanced hepatocellular carcinoma previously treated with sorafenib: 5-year results from CheckMate 040.. Ann Oncol. https://doi.org/10.1016/j.annonc.2024.03.005
Source records
- europe-pmc · retrieved 2026-09-26T11:05:04.294Z